Gadolinium complex of DO3A-benzothiazole aniline (BTA) conjugate as a theranostic agent.
Hee-Kyung Kim, Min-Kyoung Kang, Ki-Hye Jung, Sun-Hee Kang, Yeoun-Hee Kim, Jae-Chang Jung, Gang Ho Lee, Yongmin Chang, Tae-Jeong Kim
文献索引:J. Med. Chem. 56(20) , 8104-11, (2013)
全文:HTML全文
摘要
A gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7-trisacetic acid (DO3A) and benzothiazole-aniline (BTA) of the type [Gd(DO3A-BTA)(H2O)] has been prepared for use as a single molecule theranostic agent. The kinetic inertness and r1 relaxivity (= 3.84 mM(-1) s(-1)) of the complex compare well with those of structurally analogous Gd-DOTA. The same complex is not only tumor-specific but also intracellular, enhancing MR images of cytosols and nuclei of tumor cells such as MCF-7, MDA-MB-231, and SK-HEP-1. Both DO3A-BTA and Gd(DO3A-BTA) reveal antiproliferative activities as demonstrated by GI50 and TGI values obtainable from the cell counting kit-8 (CCK-8) assays performed on these cell lines. Ex vivo and in vivo monitoring of tumor sizes provide parallel and supportive observations for such antiproliferative activities.
相关化合物
相关文献:
2009-01-01
[Bioorg. Med. Chem. 17 , 896-904, (2009)]
2015-04-01
[Environ. Sci. Pollut. Res. Int. 22(8) , 5842-9, (2015)]
2013-01-01
[Bioorg. Med. Chem. Lett. 23(1) , 287-90, (2013)]
2012-08-01
[Bioorg. Med. Chem. Lett. 22(15) , 4998-5002, (2012)]
2013-03-01
[ChemMedChem 8(3) , 462-74, (2013)]